Literature DB >> 24927964

Intrahepatic flow redistribution in patients treated with radioembolization.

Carlo Spreafico1, Carlo Morosi, Marco Maccauro, Raffaele Romito, Rodolfo Lanocita, Enrico M Civelli, Carlo Sposito, Sherrie Bhoori, Carlo Chiesa, Laura F Frigerio, Alice Lorenzoni, Tommaso Cascella, Alfonso Marchianò, Vincenzo Mazzaferro.   

Abstract

INTRODUCTION: In planning Yttrium-90 ((90)Y)-radioembolizations, strategy problems arise in tumours with multiple arterial supplies. We aim to demonstrate that tumours can be treated via one main feeding artery achieving flow redistribution by embolizing accessory vessels.
METHODS: One hundred (90)Y-radioembolizations were performed on 90 patients using glass microspheres. In 19 lesions/17 patients, accessory branches were found feeding a minor tumour portion and embolized. In all 17 patients, the assessment of the complete perfusion was obtained by angiography and single photon emission computerized tomography-computerized tomography (SPECT-CT). Dosimetry, toxicity, and tumor response rate of the patients treated after flow redistribution were compared with the 83 standard-treated patients. Seventeen lesions in 15 patients with flow redistribution were chosen as target lesions and evaluated according to mRECIST criteria.
RESULTS: In all patients, the complete tumor perfusion was assessed immediately before radioembolization by angiography in all patients and after the (90)Y-infusion by SPECT-CT in 15 of 17 patients. In the 15 assessable patients, the response rate in their 17 lesions was 3 CR, 8 PR, and 6 SD. Dosimetric and toxicity data, as well tumour response rate, were comparable with the 83 patients with regular vasculature.
CONCLUSIONS: All embolization procedures were performed successfully with no complications, and the flow redistribution was obtained in all cases. Results in term of toxicity, median dose administered, and radiological response were comparable with standard radioembolizations. Our findings confirmed the intratumoral flow redistribution after embolizing the accessory arteries, which makes it possible to treat the tumour through its single main feeding artery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24927964     DOI: 10.1007/s00270-014-0921-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  7 in total

Review 1.  Planning Arteriography for Yttrium-90 Microsphere Radioembolization.

Authors:  Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.

Authors:  Nicholas Fidelman; Robert K Kerlan; Randall A Hawkins; Miguel Pampaloni; Andrew G Taylor; Maureen P Kohi; K Pallav Kolli; Chloe E Atreya; Emily K Bergsland; R Kate Kelley; Andrew H Ko; W Michael Korn; Katherine Van Loon; Ryan M McWhirter; Jennifer Luan; Curt Johanson; Alan P Venook
Journal:  J Gastrointest Oncol       Date:  2016-12

Review 3.  Radioembolization for the Treatment of Hepatocellular Carcinoma: The Road to Personalized Dosimetry and Ablative Practice.

Authors:  Cynthia De la Garza-Ramos; Beau B Toskich
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

4.  Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.

Authors:  T Susanna Meijer; Lioe-Fee de Geus-Oei; Christian H Martini; Fred G J Tijl; M Elske Sitsen; Arian R van Erkel; Rutger W van der Meer; Ellen Kapiteijn; Alexander L Vahrmeijer; Mark C Burgmans
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

Review 5.  Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.

Authors:  Mark C Burgmans; Eleonora M de Leede; Christian H Martini; Ellen Kapiteijn; Alexander L Vahrmeijer; Arian R van Erkel
Journal:  Cardiovasc Intervent Radiol       Date:  2015-12-30       Impact factor: 2.740

6.  Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities.

Authors:  Jens Hemmingsson; Jonas Högberg; Johan Mölne; Johanna Svensson; Peter Gjertsson; Magnus Rizell; Olof Henrikson; Peter Bernhardt
Journal:  Adv Radiat Oncol       Date:  2018-04-30

7.  The Efficacy of Coil Embolization to Obtain Intrahepatic Redistribution in Radioembolization: Qualitative and Quantitative Analyses.

Authors:  Ahmed A Alsultan; Caren van Roekel; Maarten W Barentsz; Arthur J A T Braat; Pieter Jan van Doormaal; Marnix G E H Lam; Maarten L J Smits
Journal:  Cardiovasc Intervent Radiol       Date:  2019-10-24       Impact factor: 2.740

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.